Report Detail

Medical Devices & Consumables Global Acellular Dermal Matrix (ADM) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4662712
  • |
  • 31 December, 2025
  • |
  • Global
  • |
  • 108 Pages
  • |
  • GIR
  • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Acellular Dermal Matrix (ADM) market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Acellular Dermal Matrix (ADM) is a biomaterial used in various surgical procedures, derived from human or animal skin tissue that has been processed to remove all cells, leaving behind a matrix of collagen and elastin fibers. This matrix serves as a scaffold to support tissue regeneration and healing by allowing the patient's own cells to populate and grow into the structure. ADM is commonly used in reconstructive surgeries, such as breast reconstruction, hernia repairs, and wound healing, because it provides structural support and promotes integration with the surrounding tissue. The acellular nature of the matrix reduces the risk of immune rejection and inflammatory responses, making it a versatile and effective tool in modern surgical practices​​.
This report is a detailed and comprehensive analysis for global Acellular Dermal Matrix (ADM) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Acellular Dermal Matrix (ADM) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Acellular Dermal Matrix (ADM) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Acellular Dermal Matrix (ADM) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Acellular Dermal Matrix (ADM) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Acellular Dermal Matrix (ADM)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Acellular Dermal Matrix (ADM) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AlloDerm (AbbVie), Zimmer Biomet, Stryker, DeCell Technologies, MatriDerm, MTF Biologics, Smith+Nephew, Medtronic, RTI Surgical, Straumann, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Acellular Dermal Matrix (ADM) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Allogeneic ADM (Human Origin)
Xenogeneic ADM (Animal Origin)
Market segment by Application
Tissue Repair
Plastic Surgery
Others
Major players covered
AlloDerm (AbbVie)
Zimmer Biomet
Stryker
DeCell Technologies
MatriDerm
MTF Biologics
Smith+Nephew
Medtronic
RTI Surgical
Straumann
AlloSource
Unitrump
Lthink
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Acellular Dermal Matrix (ADM) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Acellular Dermal Matrix (ADM), with price, sales quantity, revenue, and global market share of Acellular Dermal Matrix (ADM) from 2020 to 2025.
Chapter 3, the Acellular Dermal Matrix (ADM) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Acellular Dermal Matrix (ADM) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Acellular Dermal Matrix (ADM) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Acellular Dermal Matrix (ADM).
Chapter 14 and 15, to describe Acellular Dermal Matrix (ADM) sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Acellular Dermal Matrix (ADM) Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Allogeneic ADM (Human Origin)
    • 1.3.3 Xenogeneic ADM (Animal Origin)
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Acellular Dermal Matrix (ADM) Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Tissue Repair
    • 1.4.3 Plastic Surgery
    • 1.4.4 Others
  • 1.5 Global Acellular Dermal Matrix (ADM) Market Size & Forecast
    • 1.5.1 Global Acellular Dermal Matrix (ADM) Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Acellular Dermal Matrix (ADM) Sales Quantity (2020-2031)
    • 1.5.3 Global Acellular Dermal Matrix (ADM) Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 AlloDerm (AbbVie)
    • 2.1.1 AlloDerm (AbbVie) Details
    • 2.1.2 AlloDerm (AbbVie) Major Business
    • 2.1.3 AlloDerm (AbbVie) Acellular Dermal Matrix (ADM) Product and Services
    • 2.1.4 AlloDerm (AbbVie) Acellular Dermal Matrix (ADM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 AlloDerm (AbbVie) Recent Developments/Updates
  • 2.2 Zimmer Biomet
    • 2.2.1 Zimmer Biomet Details
    • 2.2.2 Zimmer Biomet Major Business
    • 2.2.3 Zimmer Biomet Acellular Dermal Matrix (ADM) Product and Services
    • 2.2.4 Zimmer Biomet Acellular Dermal Matrix (ADM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Zimmer Biomet Recent Developments/Updates
  • 2.3 Stryker
    • 2.3.1 Stryker Details
    • 2.3.2 Stryker Major Business
    • 2.3.3 Stryker Acellular Dermal Matrix (ADM) Product and Services
    • 2.3.4 Stryker Acellular Dermal Matrix (ADM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Stryker Recent Developments/Updates
  • 2.4 DeCell Technologies
    • 2.4.1 DeCell Technologies Details
    • 2.4.2 DeCell Technologies Major Business
    • 2.4.3 DeCell Technologies Acellular Dermal Matrix (ADM) Product and Services
    • 2.4.4 DeCell Technologies Acellular Dermal Matrix (ADM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 DeCell Technologies Recent Developments/Updates
  • 2.5 MatriDerm
    • 2.5.1 MatriDerm Details
    • 2.5.2 MatriDerm Major Business
    • 2.5.3 MatriDerm Acellular Dermal Matrix (ADM) Product and Services
    • 2.5.4 MatriDerm Acellular Dermal Matrix (ADM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 MatriDerm Recent Developments/Updates
  • 2.6 MTF Biologics
    • 2.6.1 MTF Biologics Details
    • 2.6.2 MTF Biologics Major Business
    • 2.6.3 MTF Biologics Acellular Dermal Matrix (ADM) Product and Services
    • 2.6.4 MTF Biologics Acellular Dermal Matrix (ADM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 MTF Biologics Recent Developments/Updates
  • 2.7 Smith+Nephew
    • 2.7.1 Smith+Nephew Details
    • 2.7.2 Smith+Nephew Major Business
    • 2.7.3 Smith+Nephew Acellular Dermal Matrix (ADM) Product and Services
    • 2.7.4 Smith+Nephew Acellular Dermal Matrix (ADM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Smith+Nephew Recent Developments/Updates
  • 2.8 Medtronic
    • 2.8.1 Medtronic Details
    • 2.8.2 Medtronic Major Business
    • 2.8.3 Medtronic Acellular Dermal Matrix (ADM) Product and Services
    • 2.8.4 Medtronic Acellular Dermal Matrix (ADM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Medtronic Recent Developments/Updates
  • 2.9 RTI Surgical
    • 2.9.1 RTI Surgical Details
    • 2.9.2 RTI Surgical Major Business
    • 2.9.3 RTI Surgical Acellular Dermal Matrix (ADM) Product and Services
    • 2.9.4 RTI Surgical Acellular Dermal Matrix (ADM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 RTI Surgical Recent Developments/Updates
  • 2.10 Straumann
    • 2.10.1 Straumann Details
    • 2.10.2 Straumann Major Business
    • 2.10.3 Straumann Acellular Dermal Matrix (ADM) Product and Services
    • 2.10.4 Straumann Acellular Dermal Matrix (ADM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Straumann Recent Developments/Updates
  • 2.11 AlloSource
    • 2.11.1 AlloSource Details
    • 2.11.2 AlloSource Major Business
    • 2.11.3 AlloSource Acellular Dermal Matrix (ADM) Product and Services
    • 2.11.4 AlloSource Acellular Dermal Matrix (ADM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 AlloSource Recent Developments/Updates
  • 2.12 Unitrump
    • 2.12.1 Unitrump Details
    • 2.12.2 Unitrump Major Business
    • 2.12.3 Unitrump Acellular Dermal Matrix (ADM) Product and Services
    • 2.12.4 Unitrump Acellular Dermal Matrix (ADM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Unitrump Recent Developments/Updates
  • 2.13 Lthink
    • 2.13.1 Lthink Details
    • 2.13.2 Lthink Major Business
    • 2.13.3 Lthink Acellular Dermal Matrix (ADM) Product and Services
    • 2.13.4 Lthink Acellular Dermal Matrix (ADM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Lthink Recent Developments/Updates

3 Competitive Environment: Acellular Dermal Matrix (ADM) by Manufacturer

  • 3.1 Global Acellular Dermal Matrix (ADM) Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Acellular Dermal Matrix (ADM) Revenue by Manufacturer (2020-2025)
  • 3.3 Global Acellular Dermal Matrix (ADM) Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Acellular Dermal Matrix (ADM) by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Acellular Dermal Matrix (ADM) Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Acellular Dermal Matrix (ADM) Manufacturer Market Share in 2024
  • 3.5 Acellular Dermal Matrix (ADM) Market: Overall Company Footprint Analysis
    • 3.5.1 Acellular Dermal Matrix (ADM) Market: Region Footprint
    • 3.5.2 Acellular Dermal Matrix (ADM) Market: Company Product Type Footprint
    • 3.5.3 Acellular Dermal Matrix (ADM) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Acellular Dermal Matrix (ADM) Market Size by Region
    • 4.1.1 Global Acellular Dermal Matrix (ADM) Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Acellular Dermal Matrix (ADM) Consumption Value by Region (2020-2031)
    • 4.1.3 Global Acellular Dermal Matrix (ADM) Average Price by Region (2020-2031)
  • 4.2 North America Acellular Dermal Matrix (ADM) Consumption Value (2020-2031)
  • 4.3 Europe Acellular Dermal Matrix (ADM) Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Acellular Dermal Matrix (ADM) Consumption Value (2020-2031)
  • 4.5 South America Acellular Dermal Matrix (ADM) Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Acellular Dermal Matrix (ADM) Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Acellular Dermal Matrix (ADM) Sales Quantity by Type (2020-2031)
  • 5.2 Global Acellular Dermal Matrix (ADM) Consumption Value by Type (2020-2031)
  • 5.3 Global Acellular Dermal Matrix (ADM) Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Acellular Dermal Matrix (ADM) Sales Quantity by Application (2020-2031)
  • 6.2 Global Acellular Dermal Matrix (ADM) Consumption Value by Application (2020-2031)
  • 6.3 Global Acellular Dermal Matrix (ADM) Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Acellular Dermal Matrix (ADM) Sales Quantity by Type (2020-2031)
  • 7.2 North America Acellular Dermal Matrix (ADM) Sales Quantity by Application (2020-2031)
  • 7.3 North America Acellular Dermal Matrix (ADM) Market Size by Country
    • 7.3.1 North America Acellular Dermal Matrix (ADM) Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Acellular Dermal Matrix (ADM) Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Acellular Dermal Matrix (ADM) Sales Quantity by Type (2020-2031)
  • 8.2 Europe Acellular Dermal Matrix (ADM) Sales Quantity by Application (2020-2031)
  • 8.3 Europe Acellular Dermal Matrix (ADM) Market Size by Country
    • 8.3.1 Europe Acellular Dermal Matrix (ADM) Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Acellular Dermal Matrix (ADM) Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Acellular Dermal Matrix (ADM) Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Acellular Dermal Matrix (ADM) Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Acellular Dermal Matrix (ADM) Market Size by Region
    • 9.3.1 Asia-Pacific Acellular Dermal Matrix (ADM) Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Acellular Dermal Matrix (ADM) Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Acellular Dermal Matrix (ADM) Sales Quantity by Type (2020-2031)
  • 10.2 South America Acellular Dermal Matrix (ADM) Sales Quantity by Application (2020-2031)
  • 10.3 South America Acellular Dermal Matrix (ADM) Market Size by Country
    • 10.3.1 South America Acellular Dermal Matrix (ADM) Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Acellular Dermal Matrix (ADM) Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Acellular Dermal Matrix (ADM) Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Acellular Dermal Matrix (ADM) Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Acellular Dermal Matrix (ADM) Market Size by Country
    • 11.3.1 Middle East & Africa Acellular Dermal Matrix (ADM) Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Acellular Dermal Matrix (ADM) Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Acellular Dermal Matrix (ADM) Market Drivers
  • 12.2 Acellular Dermal Matrix (ADM) Market Restraints
  • 12.3 Acellular Dermal Matrix (ADM) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Acellular Dermal Matrix (ADM) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Acellular Dermal Matrix (ADM)
  • 13.3 Acellular Dermal Matrix (ADM) Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Acellular Dermal Matrix (ADM) Typical Distributors
  • 14.3 Acellular Dermal Matrix (ADM) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Acellular Dermal Matrix (ADM). Industry analysis & Market Report on Acellular Dermal Matrix (ADM) is a syndicated market report, published as Global Acellular Dermal Matrix (ADM) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Acellular Dermal Matrix (ADM) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report